Daniela M. Zisterer
About
Daniela M. Zisterer is a scholar working on Organic Chemistry, Molecular Biology and Cancer Research.
According to data from OpenAlex, Daniela M. Zisterer has authored 114 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Organic Chemistry, 62 papers in Molecular Biology and 20 papers in Cancer Research. Recurrent topics in Daniela M. Zisterer's work include Cancer therapeutics and mechanisms (29 papers), Synthesis and biological activity (23 papers) and Synthesis of β-Lactam Compounds (20 papers). Daniela M. Zisterer is often cited by papers focused on Cancer therapeutics and mechanisms (29 papers), Synthesis and biological activity (23 papers) and Synthesis of β-Lactam Compounds (20 papers). Daniela M. Zisterer collaborates with scholars based in Ireland, Italy and Saudi Arabia. Daniela M. Zisterer's co-authors include D. Clive Williams, Mary J. Meegan, Giuseppe Campiani, Lisa M. Greene, Niamh M. O’Boyle, David G. Lloyd, M.J. Carr, Mark Lawler, Seema M. Nathwani and Vito Nacci and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and FEBS Letters.
In The Last Decade
Daniela M. Zisterer
113 papers receiving 2.4k citations
Peers
Daniela M. Zisterer
William Leister United States
Donald S. Karanewsky United States
Rodolfo Márquez United Kingdom
Hiroyuki Miyachi Japan
Gyoonhee Han South Korea
Yoshitaka Satoh Japan
Michelle Palmer United States
Allan S. Wagman United States
Juan C. Jaén United States
Chuan Shih United States
Citations per year, relative to Daniela M. Zisterer Daniela M. Zisterer (= 1×)
peers
William Leister
Countries citing papers authored by Daniela M. Zisterer
Since
Specialization
Citations
This map shows the geographic impact of Daniela M. Zisterer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela M. Zisterer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela M. Zisterer more than expected).
Fields of papers citing papers by Daniela M. Zisterer
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Daniela M. Zisterer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela M. Zisterer. The network helps show where Daniela M. Zisterer may publish in the future.
Co-authorship network of co-authors of Daniela M. Zisterer
This figure shows the co-authorship network connecting the top 25 collaborators of Daniela M. Zisterer. A scholar is included among the top collaborators of Daniela M. Zisterer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela M. Zisterer. Daniela M. Zisterer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Malebari, Azizah M., Darren Fayne, Niamh M. O’Boyle, et al.. (2025). (E)-1-(3-(3-Hydroxy-4-Methoxyphenyl)-1-(3,4,5-Trimethoxyphenyl)allyl)-1H-1,2,4-Triazole and Related Compounds: Their Synthesis and Biological Evaluation as Novel Antimitotic Agents Targeting Breast Cancer. Pharmaceuticals. 18(1). 118–118.
2.
Twamley, Brendan, et al.. (2023). Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers. Bioorganic Chemistry. 141. 106877–106877.
3.
Stevenson, Leanne, Oliver Keminer, Björn Windshügel, et al.. (2022). Identification of Src as a Therapeutic Target in Oesophageal Adenocarcinoma through Functional Genomic and High-Throughput Drug Screening Approaches. Cancers. 14(15). 3726–3726.
4.
O’Sullivan, Maureen J., et al.. (2022). Targeting inhibitor of apoptosis proteins (IAPs) with IAP inhibitors sensitises malignant rhabdoid tumour cells to cisplatin. Cancer Treatment and Research Communications. 32. 100579–100579.
5.
Malebari, Azizah M., Brendan Twamley, Darren Fayne, et al.. (2022). Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones. Pharmaceuticals. 15(9). 1044–1044.
6.
Vanni, Francesca, Anna Kabanova, Francesca Cattaneo, et al.. (2021). A novel class of oxazepine-based anti-cancer agents induces cell death in primary human CLL cells and efficiently reduces tumor growth in Eμ-TCL1 mice through the JNK/STAT4/p66Shc axis. Pharmacological Research. 174. 105965–105965.
7.
Previtali, Viola, et al.. (2020). Exploring the Anti-Cancer Mechanism of Novel 3,4′-Substituted Diaryl Guanidinium Derivatives. Pharmaceuticals. 13(12). 485–485.
8.
Kinsella, Paula, Lisa M. Greene, Sandra A. Bright, et al.. (2016). The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15. Investigational New Drugs. 34(2). 159–167.
9.
O’Boyle, Niamh M., M.J. Carr, Andrew J. S. Knox, et al.. (2014). β-Lactam Estrogen Receptor Antagonists and a Dual-Targeting Estrogen Receptor/Tubulin Ligand. Journal of Medicinal Chemistry. 57(22). 9370–9382.
10.
Bright, Sandra A., Stefania Butini, Giuseppe Campiani, et al.. (2014). The novel pyrrolo-1,5-benzoxazepine, PBOX-6, synergistically enhances the apoptotic effects of carboplatin in drug sensitive and multidrug resistant neuroblastoma cells. Biochemical Pharmacology. 87(4). 611–624.
11.
Lysaght, Joanne, Navin Kumar Verma, Jacqueline Ryan, et al.. (2012). The microtubule targeting agent PBOX-15 inhibits integrin-mediated cell adhesion and induces apoptosis in acute lymphoblastic leukaemia cells. International Journal of Oncology. 42(1). 239–246.
12.
O’Boyle, Niamh M., M.J. Carr, Lisa M. Greene, et al.. (2011). Synthesis, biochemical and molecular modelling studies of antiproliferative azetidinones causing microtubule disruption and mitotic catastrophe. European Journal of Medicinal Chemistry. 46(9). 4595–4607.
13.
Browne, Paul, Patrick Hayden, Elisabeth Vandenberghe, et al.. (2010). PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells. British Journal of Cancer. 104(2). 281–289.
14.
Greene, Lisa M., Siobhan McGuckin, Paul Browne, et al.. (2009). The Novel Tubulin-Targeting Agent Pyrrolo-1,5-Benzoxazepine-15 Induces Apoptosis in Poor Prognostic Subgroups of Chronic Lymphocytic Leukemia. Cancer Research. 69(21). 8366–8375.
15.
Bane, Fiona T., Stephen R. Pennington, Giuseppe Campiani, et al.. (2009). The Microtubule-Targeting Agents, PBOX-6 [Pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and Paclitaxel, Induce Nucleocytoplasmic Redistribution of the Peptidyl-Prolyl Isomerases, Cyclophilin A and Pin1, in Malignant Hematopoietic Cells. Journal of Pharmacology and Experimental Therapeutics. 329(1). 38–47.
16.
Barrett, Irene, Mary J. Meegan, M.J. Carr, et al.. (2008). Synthesis, biological evaluation, structural–activity relationship, and docking study for a series of benzoxepin-derived estrogen receptor modulators. Bioorganic & Medicinal Chemistry. 16(21). 9554–9573.
17.
Mulligan, Jude M., Giuseppe Campiani, Anna Ramunno, Vito Nacci, & Daniela M. Zisterer. (2003). Inhibition of G1 cyclin-dependent kinase activity during growth arrest of human astrocytoma cells by the pyrrolo-1,5-benzoxazepine, PBOX-21. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1639(1). 43–52.
18.
Zisterer, Daniela M., Margaret M. Mc Gee, Giuseppe Campiani, et al.. (2001). Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents. Biochemical Society Transactions. 29(6). 704–704.
19.
Zisterer, Daniela M. & D. Clive Williams. (1997). Calmidazolium and other imidazole compounds affect steroidogenesis in Y1 cells: Lack of involvement of the peripheral-type benzodiazepine receptor. The Journal of Steroid Biochemistry and Molecular Biology. 60(3-4). 189–195.
20.
Woods, Margaret J., Daniela M. Zisterer, & D. Clive Williams. (1996). Two cellular and subcellular locations for the peripheral-type benzodiazepine receptor in rat liver. Biochemical Pharmacology. 51(10). 1283–1292.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by William Leister Breakdown of academic impact, for papers by Donald S. Karanewsky Breakdown of academic impact, for papers by Rodolfo Márquez Breakdown of academic impact, for papers by Hiroyuki Miyachi Breakdown of academic impact, for papers by Gyoonhee Han Breakdown of academic impact, for papers by Yoshitaka Satoh Breakdown of academic impact, for papers by Michelle Palmer Breakdown of academic impact, for papers by Allan S. Wagman Breakdown of academic impact, for papers by Juan C. Jaén Breakdown of academic impact, for papers by Chuan Shih